Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 168 clinical trials
BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

The purpose of this study is to evaluate the safety and efficacy of BUCYE conditioning regimens in primary central nervous system lymphoma undergoing autologous hematopoietic stem cell transplantation.

nervous
etoposide
cyclophosphamide
  • 5 views
  • 22 Jan, 2021
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA

acquired SAA.But some patients with high risk factors may not tolerate CTX 200mg/kg,alternative conditioning regimen including Bu/Fludarabine/dercreased CTX was studied in this trial.

conditioning regimen
fludarabine
severe aplastic anemia
aplastic anemia
cyclophosphamide
  • 0 views
  • 23 Jan, 2021
  • 1 location
Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

Recent studies demonstrated that allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be a valuable treatment choice for mixed-lineage-leukemia (MLL)-rearranged acute leukemia. Unfortunately, some patients relapsed after allo-HSCT. In this prospective randomized controlled study, the safety and efficacy of Decitabine + BUCY and BUCY myeloablative conditioning regimens in MLL+ acute leukemia …

conditioning regimen
myeloablative conditioning
decitabine
busulfan
leukemia
  • 7 views
  • 22 Jan, 2021
  • 1 location
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

best conditioning regimen for elderly AML in CR remains in discussion. In this prospective study, the safety and efficacy of Dec+Flu+Bu myeloablative conditioning regimens in patients with elderly AML

conditioning regimen
fludarabine
decitabine
remission
myeloablative conditioning
  • 15 views
  • 28 Jan, 2021
  • 1 location
Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

In this phase clinical trail, we evaluate the efficacy and feasibility of azacytidine and venetoclax as leukemia debulking treatment followed by reduced intensity conditioning regimen consisting

  • 0 views
  • 09 Jun, 2021
  • 3 locations
Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

myeloablative conditioning regimen for high-risk patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (Allo-HSCT).

conditioning regimen
decitabine
cyclophosphamide
refractory acute myeloid leukemia (aml)
myeloablative conditioning
  • 29 views
  • 21 Jan, 2021
  • 1 location
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

The purpose of this study is to evaluate the safety and efficacy of Melphalan and BUCY+VP-16 myeloablative conditioning regimens in multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

chemotherapy regimen
transplant conditioning
busulfan
cell transplantation
etoposide
  • 1 views
  • 23 Jan, 2021
  • 1 location
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

This is a Phase 1a/b study to evaluate the safety and tolerability of an antibody conditioning regimen known as JSP191, in combination with low dose radiation and fludarabine, in subjects with

  • 0 views
  • 17 Jun, 2021
  • 6 locations
Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma

The purpose of this study is to determine the correct dose and safety of adding a new cancer drug, Venetoclax, to a standard combination of chemotherapy drugs used prior to Autologous stem cell transplant (ASCT) in participants with Non-Hodgkin Lymphoma (NHL). In this study, Venetoclax will be added to BEAM …

carmustine
chemotherapy drugs
etoposide
antineoplastic
ara-c
  • 0 views
  • 24 May, 2021
  • 4 locations
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

ATG based conditioning regimen in HLA related allogeneic hematopoietic stem cell transplantation for aggressive T-cell tumors: multi-center, open, randomized controlled clinical study

  • 0 views
  • 21 Jan, 2021
  • 1 location